106 related articles for article (PubMed ID: 7473127)
1. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
Schuetz EG; Furuya KN; Schuetz JD
J Pharmacol Exp Ther; 1995 Nov; 275(2):1011-8. PubMed ID: 7473127
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.
Schuetz EG; Umbenhauer DR; Yasuda K; Brimer C; Nguyen L; Relling MV; Schuetz JD; Schinkel AH
Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution of the human MDR3 P-glycoprotein.
Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P
Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
6. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.
Schuetz EG; Schuetz JD; Strom SC; Thompson MT; Fisher RA; Molowa DT; Li D; Guzelian PS
Hepatology; 1993 Nov; 18(5):1254-62. PubMed ID: 8225233
[TBL] [Abstract][Full Text] [Related]
8. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.
Lee CH; Bradley G; Zhang JT; Ling V
J Cell Physiol; 1993 Nov; 157(2):392-402. PubMed ID: 7901227
[TBL] [Abstract][Full Text] [Related]
10. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
12. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
13. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.
Ramani P; Dewchand H
J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222
[TBL] [Abstract][Full Text] [Related]
14. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
[TBL] [Abstract][Full Text] [Related]
15. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response.
Ng IO; Liu CL; Fan ST; Ng M
Am J Clin Pathol; 2000 Mar; 113(3):355-63. PubMed ID: 10705815
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes.
Schuetz JD; Schuetz EG
Cell Growth Differ; 1993 Jan; 4(1):31-40. PubMed ID: 8424904
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
[TBL] [Abstract][Full Text] [Related]
19. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
[TBL] [Abstract][Full Text] [Related]
20. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
